盛恩(Thinova)医药
Think & Innovation
诚信服务 合作共赢
Honest service Cooperation and win-win
1
公司简介 Company Profile
2
3
发展史
Thinova’s development milestones 
盛恩（北京）医药科
技有限公司
Thinova (Beijing) 
Medical Science and 
Technology Co., Ltd.
源方（北京）医药科技有限公司
Regpharmed (Beijing) Medical 
Science and Technology Co., Ltd.
医之邦（北京）医学研究有限公司
Esponmed (Beijing) Medical Research Co., Ltd.
器械临床试验CRO
Device Clinical Trials CRO
欧迪特（北京）医学研究有限公司
Audit (Beijing) Medical Research Co., Ltd.
第三方稽查团队
Third-party audit team
年业务量突破7000万
Annual business volume 
exceed RMB 70 million
 规模超150人
 More than 150 employees
 年营业额稳定两年过亿元
 Annual business volume 
exceed RMB 100 million
 稳固行业第一梯队CRO地位
 Solidify the first-tier CRO 
position in the industry
 与国企达成合作
 Achieve cooperation with 
state-owned enterprises
 与跨国公司达成合作
 Achieve cooperate with 
multinational companies
 与多家国内上市企业达成合作
 Achieve cooperation with a 
number of domestic listed 
enterprises.
泽瀚（北京）科技有限公司
Zievr(Beijing) Technology Co., Ltd
核心实验室团队
Core Laboratory Team
SMO团队
SMO service, providing one￾stop service for clinical trials
•欧迪特（北京）医学研究有限公司——第三方稽查；
•泽瀚（北京）科技有限公司——核心实验室；
•铄源（北京）管理咨询有限公司——财务顾问。
配套业务简介
4
•注册地址：北京；
•CRC覆盖12个市区包括：沈阳、天津、北京、石家庄、太原、
西安、郑州、武汉、合肥、上海、长沙、广州
SMO简介（源方）
•注册地址：北京；办事处：沈阳、郑州
•专注于医疗器械临床研究和注册业务；
• 3名DM 、18名PM、20名APM及几十名CRA覆盖全国22个
省/直辖市，本科以上学历占比95%。
CRO简介（盛恩&医之邦）
CRA驻地
CRC驻地
无驻地
盛恩架构
• Audit (Beijing) Medical Research Co., Ltd.——Third party audit；
• Zievr(Beijing) Technology Co., Ltd——Core laboratory；
• Shuoyuan（beijing）Management Consulting Co.,Ltd——Financial advisors。
Introduction to supporting services
5
• Registration address: Beijing；
• CRC covers 12 core cities including：Shenyang, Tianjin, Beijing, Shijiazhuang, 
Taiyuan, Xi 'an, Zhengzhou, Wuhan, Hefei, Shanghai, Changsha, Guangzhou 
Introduction to SMO (Regpharmed)
• Registration address: Beijing; Office: Shenyang, Zhengzhou
• Focus on medical device clinical trials and registration businesses；
• Three DMS, 18 PMS, 20 APMs and dozens of CRAs covered 22 provinces, and 95% 
of them have bachelor's degree or above。
Introduction to CRO (Thinova&Esponmed)
CRA covered areas
CRC covered areas
Uncovered areas
Brief introduction to Thinova
公司架构图
Organization chart
盛恩事业群
Business divisions
事业发展中心
Business Development 
Center
商务部
Business 
Department
采购部
Purchasing 
Department
人力行政部
Human 
Resource 
Administratio
n Department
财务部
Finance 
Department
盛恩CRO
CRO Thinova
临床
Clinical 
Center
一中心
Clinical Department 
I
二中心
Clinical Department 
II
三中心
Clinical Department 
III
支持部
Clinical Support 
Department
医学统计
Medical&statistics Cente
r
注册事务
Registration 
Affairs Center
欧迪特
Audit
培训部
Training 
Department
药品稽查部
Pharmaceutical 
Inspection 
Department
器械核查部
Equipment 
Inspection 
Department
源方SMO
SMO Regpharmed
临床协调中心
Clinical 
Coordination 
Center
泽瀚（核心实验室）
Zievr(Core laboratory)
技术部
Technical 
Department
专家联络部
Expert Liaison 
Department
医之邦CRO 
CRO Esponmed
临床部
Clinical 
Department
质量部
Quality Department
培训部
Training Department
铄源资本
（FA财务顾问）
Shuoyuan
Financial Advisors
6
总经理
General Manager 
总经理：李成立
General Manager：Li Chengli 
工作地点：北京
Workplace: Beijing
器械临床工作年限：20年
Experience in device related clinical works: 20 years
从业经验：
Resume:
 2003年进入医疗器械CRO公司；
 Engaged in medical device clinical trial and registration works in China since 2003;
 知名上市CRO公司副总经理；
 Deputy general manager of well-known listed CRO company;
 大型心血管器械生产研发企业临床总监；
 Clinical director of a large cardiovascular device manufacturing and R&D enterprise;
取得的注册证：截止目前，主导完成了包括高值耗材、大型有源器械在内的几十余项临床试验和产品的注册。
Registration certificates acquired: By now, tens of clinical trials and registrations of products, including high 
value consumables and large active devices have been completed under his guidance.
7
8
临床及质量
Clinical Department 
临床一中心：赵海霞
Manager of Clinical 
Department I:
Zhaohaixia
器械临床工作年限：14年
Experience in device related 
clinical works: 14 years
专业：临床药学专业
Major: Clinical Pharmacy
取得的注册证：8个
Registration certificates 
acquired: 8
临床二中心：孙永振
Manager of Clinical 
Department II:
Sun Yongzhen
器械临床工作年限：11年
Experience in device related 
clinical works: 11 years
专业：临床医学专业
Major: Clinical Medicine
取得的注册证：8个
Registration certificates 
acquired: 8
临床三中心：唐晓梅
Manager of Clinical 
Department III: 
Tang Xiaomei
器械临床工作年限：10年
Experience in device related 
clinical works: 10 years
专业：临床药学专业
Major: Clinical Pharmacy
取得的注册证：8个
Registration certificates 
acquired: 8
临床协调部：赵莹
Manager of Clinical Support 
Department: 
Zhao Ying
器械临床工作年限：10年
Experience in device related 
clinical works: 10 years
专业：生物学专业
Major: Biology
取得的注册证：15个
Registration certificates 
acquired: 15
质量中心：窦国龙
Quality Department :
Dou Guolong
器械临床工作年限：15年
Experience in device related 
clinical works: 15 years
专业：临床医学专业
Major: Clinical Medicine
取得的注册证：13个
Registration certificates 
acquired: 13
9
SMO区域管理人员
SMO Regional Manager
SMO三中心：范奇梅
SMO Department III:Fanqimei
工作地点：上海
Workplace: Shanghai
工作年限：6年
Working experience: 6years
管理区域：沪
Administrative area:Shanghai
SMO一中心：王锴锴
SMO Department I:Wangkaikai
工作地点：石家庄
Workplace: Shijiazhuang
工作年限：8年
Working experience: 8 years
管理区域：冀、津、京、晋、辽
Administrative area:Hebei 
Tianjin Beijing Shanxi Liaoning
SMO四中心：喻丹
SMO Department IV:Yudan 
工作地点：武汉
Workplace: Wuhan
器械临床工作年限：8年
Working experience: 8 years
管理区域：粤、鄂、湘
Administrative
area:Guangdong Hubei Hunan
SMO二中心：丰平
SMO Department II:Fengping
工作地点：郑州
Workplace: Zhengzhou
工作年限：7年
Working experience: 7 years
管理区域：豫、鲁、陕
Administrative area:Henan 
Shandong Shanxi
我们的服务
Services & Experience
我们的服务
Our services
独立影像评估
Independent 
imaging 
assessment 第三方稽查
Third party 
audit 临床试验
临床研究
Clinical trial
Clinical research
产品注册
创新申报
Product registration
Innovation submission
 全流程管理
 Whole process management
 一站式服务
 One-stop service
 客户利益第一位
 Customers’ interests first
我们承诺
Our commitments
数据管理
统计分析
Data management
Statistical analysis
11
客户简介
Client
 Medentis（门登特斯）
 Fotona（欧洲之星）
 Fresenius（费森尤斯）
德国/GER
 Panasonic(松下）
日本/JPN
 BD（碧迪）
 Cynosure（赛诺秀）
美国/US
12
 先健科技/LifeTech Scientific 
 信立泰药业/Salubris Pharmaceuticals
 乐普医疗/Lepu Medical
 心玮医疗/ HeartCare Medical
 新华医疗/Shinva Medical
 凯利泰/Kinetic Medical 
 锦江电子/Jinjiang Electronic 
 蓝帆医疗/Blue Sail Medical 
 健适医疗/Genesis Medtech
 健世科技/ Jenscare Scientific
 宜安生物/Dongguan Eontec 
 华熙生物/Bloomage Biotechnology 
 微创医疗/MicroPort Scientific
 启明医疗/Qiming Medical
 深圳半岛/ Peninsula Medical
 南京百福/ Bestview Laser
 山东庄成/Zhuangcheng Laser 
 重庆美微/MeiWei Medical
中国CN：上市公司The listed 
company&美容公司Plastic Surgery 
company
 Venus Concept（维锶）
以色列/ISR
 Straumann（士卓曼）
瑞士/CH
13
心脏
Cardiology
脑保护装置 — — 脑卒中
Brain protection devices – stroke
封堵器 — — 左心耳封堵
Occlusion device – left atrial appendage occlusion
延长导管 — — 冠状动脉
Prolonged catheter – Coronary artery
房间隔造孔支架 — — 心 衰
Atrial septal stents – Heart failure
药物球囊 — — 再狭窄
Drug-coated balloon – Restenosis
药物球囊 — — 分叉病变
Drug-coated balloon – Bifurcation lesion
药物球囊 — — 小血管
Drug-coated balloon – small vessel
药物球囊 — — 原发病变
Drug-coated balloon – De novo lesion
载药支架 — — 冠状动脉
Drug-eluting stent – Coronary artery
心房分流导管 — — 心 衰
Atrial shunt catheter – Heart failure
可降解 3 D 支 架 — — 冠状动脉
Biodegradable 3D stent – Coronary artery
卵圆孔未闭封堵器 — — 卵圆孔未闭
Patent foramen ovale occluder – Patent 
foramen ovale
14
心肺
Cardiopulmonary
三维标测消融系统 — — 房 颤
3d mapping system – Atrial fibrillation
取栓系统 — — 肺栓塞
Embolectomy – pulmonary embolism
冷冻消融系统 — — 房 颤
Cryoablation System – Atrial fibrillation
脉冲消融系统 — — 房 颤 / 室上速
Pulse ablation system – Atrial fibrillation
肺水治疗仪 — — 心 衰
Lung water therapy instrument – congestive heart failure
舒适睡眠系统 — — 睡 眠
Comfortable sleep system – Sleep
支气管内活瓣 — — 肺减容
Endobronchial valve – Lung volume reduction
15
射频消融系统 — — 肝 癌
Radiofrequency ablation systems --
Liver cancer
聚乙烯醇栓塞微球 — — 肝 癌
Polyvinyl alcohol embolization 
microspheres -- Liver cancer
纳秒脉冲消融系统 — — 甲状腺癌
Nanosecond pulse ablation system --
Thyroid cancer
乳腺肿瘤 — — 乳房微创旋切系统
Breast neoplasms -- Minimally invasive 
mastectomy system
胰腺癌 — — 高压电脉冲消融系统
Pancreatic cancer -- high voltage 
electrical pulse ablation system
肝 癌 — — 聚乙二醇栓塞微球
Hepatocellular carcinoma --
polyethylene glycol embolization 
microspheres
肿瘤
Tumor
16
血管
Cardiovascular System
• 颅内支架 — — 动脉瘤
Intracranial stent-Aneurysm
• 颅内球囊扩张导管 — — 动脉血栓
Intracranial Balloon Dilattation Catheter— —Arteriostenosis
• 神经微导管 — — 输 送
Nerve Micro-catheter —Convery
• 弹簧圈 — — 动脉瘤
Helical coils— —Aneurysm
• 支 架 — — 颈动脉狭窄
Carotid Artery Stent— — Carotid Artery Stenosis
• 保护伞 — — 颈动脉狭窄
Umbralla— —Carotid Artery Stenosis
• 可降解铁支架 — — 股腘动脉
Iron alloy bioabsorbable stent system— — Femoral Popliteal Artery
• 3 D 打印全降解支架 — — 股腘动脉
3D Fully Biodegradable Stent — —Superficial Femoral Artery
• 药物球囊 — — 股腘动脉
Drug-coated balloon— — Femoral Popliteal Artery
• 能量球囊 — — 股腘动脉
Energy-assisted Balloon— — Femoral Popliteal Artery
• 滤 器 — — 腔静脉血栓
Filter — Vena Cava Thrombosis
• 支 架 — — 髂静脉血栓
Stent—Iliac Vein Thrombosis
• 超声溶栓系统 — — 静脉血栓
Ultrasonic thrombolytic system￾Venous thrombosis
• 射 频 / 微波系统 — — 大隐静脉曲张
Microwave System — Great Saphenous Varicose
• 静脉闭合胶 — — 大隐静脉曲张
RF System — Great Saphenous Varicose • 编织支架 — — 股腘动脉
Braided Stent — — Femoral Popliteal Artery
其他外科手术
Other Surgical Procedure
17
透明质酸钠——鼻背和/或鼻根整形
Hyaluronic Acid—Rhinoplasty
透明质酸钠——中、重度鼻唇沟皱纹
Hyaluronic Acid——mid- to deep dermal nasolabial fold
射频微针治疗仪——痤疮瘢痕
RF Micro-needling——Acne Scar
激光设备——雀斑、纹身、皱纹、溶脂
Laser System - freckles, tattoos, wrinkles, lipolysis
超声刀——面部提拉
High-intensity Focused Ultrasound System – Facial skin 
tightening
面部整形
Facial Plastic
乳房微创旋切系统——活检
Minimally Invasive Breast Rotation System—
Biopsy
激光治疗仪——尿失禁
laser therapeutic instrument——Uracratia
妇科领域
Gynaecology
止血敷料——止血
Hemostatic Dressing—Hemostasis
可吸收止血纱布//海绵——止血
Absorbable Hemostatic Gauze // Sponge —Hemostasis
生物羊膜——慢性创面
Amniotic membrane —Chronic wound
皮肤及黏膜
Skin and Mucosa
超声刀——腔镜手术
Ultrasound System——Endoscopic Surgery
电子腹腔镜——腔镜手术
Laparoscope——Endoscopic Surgery
疝气补片——腹股沟疝
Hernia Solutions——Inguinal Hernia
胃转流支架——减重
Biliopancreatic Stent——Loss Weight
血液灌流器——透析
Hemoperfusion——Dialysis
其他器官与周围组织
Other organs and Surrounding Tissues
我们与美容
We and Aesthetics
19
美容领域项目经验
申办方 项目名称 适应症 提供服务类型 进度阶段
华熙生物 注射用修饰透明质酸钠凝胶
中重度鼻唇部皱纹 临床试验 国械注准20203130569
额部皱纹 临床试验 国械注准20203130295
河南汇博 医用硅酮凝胶 祛疤 临床试验 豫械注准20182140641
郑州品正 IPL 脱毛 临床试验 豫械注准20202091633
Cynosure 激光溶脂仪 激光溶脂 医学相关文件设计及更新 国械注进20223090386
Cynosure
TempSure Firm 妊娠纹 医学相关文件设计及更新
递交阶段
TempSure Envi 面部皱纹 医学相关文件设计及更新
深圳半岛 射频微针治疗仪 痤疮瘢痕 临床试验
执行中
Fotona
Er 激光 压力性尿失禁 临床试验
NA YAG 雀斑 临床试验
南京佰福 皮秒 雀斑 临床试验
山东庄成 皮秒 蓝黑纹身 临床试验
重庆美微 HIFU 面部提拉 临床试验
20
Cosmetology project experience
Sponsor Name of Project Indications For Use Type of Service Provided Stage of Progress
Bloomage Biotech Modified Sodium Hyaluronate Gel For 
Injection
Moderate To Severe Nasolabial 
Wrinkles
Clinical Trials National Device Registration No. 
20203130569
Forehead Wrinkles Clinical Trials National Device Registration No. 
20203130295
Huibo Medlcal Medical Silicone Gel Scar Removal Clinical Trials Henan Device Registration 
20182140641
Zhengzhou Pz IPL Hair Removal Clinical Trials Henan Device Registration 
20202091633
Cynosure Laser Lipolysis Instrument Laser Lipolysis Design And Update Of Medical Related 
Documents
National Device Registration (for 
import) 20223090386
Cynosure
Tempsure Firm Stretch Marks Design And Update Of Medical 
Documents Stage Of Submission
Tempsure Envi Facial Wrinkles Design And Update Of Medical 
Documents
Peninsula Radiofrequency Microneedle Therapy
System
Acne Scars Clinical Trials
In Execution
Fotona
Er Laser Stress Urinary Incontinence Clinical Trials
Na Yag Freckles Clinical Trials
Nanjing Bestview Picosecond Laser System Freckles Clinical Trials
Zhuangcheng Laser Picosecond Laser System Blue And Black Tattoo Clinical Trials
Chongqing Meiwei Hifu Facial Skin Tightening Clinical Trials
21
注射类临床经验分享
Clinical experience sharing of injections
申办方
Sponsor
适应症
Indications For Use
研究中心
Study Sites
入组周期
Entry Period
华熙生物科技股份有限公司
Bloomage Biotechnology Corporation 
Limited
注射用交联透明质酸钠凝胶
Cross-linked Sodium Hyaluronate Gel 
For Injection
中重度鼻唇部皱纹
Moderate To Severe 
Nasolabial Folds
北京医院（牵头）
Beijing Hospital (Coordinating)
中国人民解放军空军特色医学中心
PLA Air Force Medical Center
3month
额部皱纹
Forehead Wrinkles
北京医院（牵头）
Beijing Hospital (Coordinating)
内蒙古医科大学附属医院
Affiliated Hospital of Inner Mongolia Medical University
北部战区总医院
General Hospital of Northern Theater Command
广州军区总医院
General Hospital of Guangzhou Military Region
中国人民解放军空军特色医学中心
PLA Air Force Medical Center
6month
医学分析
Medical analysis
统计支持
姓名：姚晨，教授
北京大学第一医院医学统计室主任，北京大学临床研究所副所长，临床研究(方法)学博士生导师
研究方向：临床研究的统计设计与分析、临床研究的数据管理
主要学术任职有中国医师协会第四届循证医学专业委员会主任委员、中国卫生信息学会第六届统计理论与方法专业委
员会副主任委员、世界中医药学会联合会第三届临床疗效评价专业委员会副会长、国家食品药品监督管理局药品/器械审评
专家库专家。
姚晨教授是国内较早参与规范我国临床试验数据管理与统计分析的知名生物统计学专家，曾参与了国家药品监督管理
局(NMPA)有关新药/医疗器械的临床研究技术指导原则和相应法规的制定和修改工作。作为NMPA外部审评专家，参加了许
多国家新药/医疗器械的技术审评工作，以及“临床试验质量管理规范(GCP)”培训授课工作,每年完成数百项临床试验设计。
23
Statistical support
Name: Yao Chen, Professor
Director of Department of Medical Statistics, Peking University First Hospital; 
Deputy Director of Peking University Clinical Research Institute,
PhD supervisor of clinical research (methodology)
Research interests: Statistical design and analysis of clinical trial, data management of clinical trial.
Professor Yao’s main academic positions include Director of the 4th Professional Committee on Evidence-based 
Medicine of the Chinese Medical Association, Deputy Director of the 6th Professional Committee on Statistical Theory and 
Methods of the Chinese Society of Health Information, Vice President of the 3rd Professional Committee on Clinical Efficacy 
Evaluation of the World Federation of Chinese Medicine Societies, and expert of the NMPA’s Drug/Device Review Expert Pool. 
Professor Yao Chen is a well-known biostatistician who participated in the standardization of clinical trial data 
management and statistical analysis in China. He has participated in the formulation and revision of the National Medical 
Products Administration (NMPA) clinical research technical guidelines and corresponding regulations for new drugs/medical 
devices. As an external reviewer of the NMPA, he has participated in the technical review of many new drugs/medical devices 
in China, as well as the training and lectures of "GCP", and has completed hundreds of clinical trial designs every year.
24
25
医学支持
Medical Support
医学撰写：张毓晋
Medical writer: Zhang YuJin
工作年限：6年
Length of service: 6 years
方案撰写：60+
Protocol writing: 60+
涉及领域：美容、心脏、肿瘤、神经、血管
Fields: aesthetic, cardiac, oncology, neurology, vascular
医学主审核：王美君
Medical reviewer: Wang Meijun
工作年限：8年
Length of service: 8 years
参与医学设计：150+
Participating in medical design: 150+
辅助审核：李成立、窦国龙、唐晓梅、孙永振、赵婧妍、王雪、毛世杰
Auxiliary audit:Li Chengcheng, Dou Guolong, Tang Xiaomei, Sun 
Yongzhen, Zhao Jingyan, Wang Xue, Mao Shijie
26
试验设计
Design OF THE TRIAL
项目名称
Study Name
评价射频治疗仪用于治疗面部痤疮萎缩性瘢痕的安全性和有效性
Evaluation of the safety and efficacy of the radiofrequency therapy device in the 
treatment of facial acne atrophic scars
试验设计
Study Design
多中心、随机、对照临床试验
A multicenter, randomized, controlled clinical trial
对照组
Control Group
产品名称：射频微针治疗仪+射频微针电极
Product: Radiofrequency microneedle therapeutic instrument + radiofrequency 
microneedle electrode
公司名称：杰希思医疗公司
Corporation: Jeisys Medical Inc.
样本量
Sample Size
90对，180例
90 pairs, 180 cases
中心数
Number of Centers
3 Sites
试验周期
Period of Study
25 Months
入选标准
Inclusion criteria
 18周岁≤年龄≤50周岁，性别不限；
 18 years old ≤ age ≤50 years old, regardless of gender;
 面部痤疮萎缩性瘢痕需要射频治疗者；
 Patients with facial acne atrophic scar requiring radiofrequency treatment;
 患者自愿参加本研究并签署知情同意书者；
 Patients voluntarily participate in the study and sign the informed consent form;
27
28
排除标准
1. 3个月内面部瘢痕接受过外科治疗（皮肤磨削术等）、化学剥脱术或光电治疗（激光或射频治疗等）的患者；
2. 3个月内接受过面部注射填充物的患者；
3. 治疗部位存在增生性瘢痕、瘢痕疙瘩或有金属植入物的患者；
4. 有进展期痤疮或3个月内使用过维A酸类药物的患者；
5. 严重凝血功能障碍(凝血检查任一指标大于正常值上限2倍)的患者；
6. 过敏体质或瘢痕体质及皮肤癌患者；
7. 治疗部位有皮肤受损或感染者；
8. 患有严重的系统性疾病（心血管疾病、肝病、肾病、糖尿病等）者；
9. 植入心脏起搏器的患者；
10. 3个月内参加过或正在参加其他药物或医疗器械临床试验的患者；
11. 妊娠或哺乳期女性患者；
12. 研究者认为其他不适合参加本次临床试验的情况；
适应症排除
手术排除
临床试验排除
29
Exclusion Criteria
1. Patients who have received surgical treatment (dermabrasion, etc.), chemical exfoliation or photoelectric treatment (laser or radiofr
equency treatment, etc.) for facial scars within 3 months;
2. Patients who have received facial filler injections within 3 months;
3. Patients with hypertrophic scars, keloids or metal implants at the treatment site;
4. Patients with advanced acne or use of retinoids within 3 months;
5. Patients with severe coagulation disorders (coagulation tests with any indicator greater than 2 times the upper limit of normal);
6. Patients with allergies or scar constitution or skin cancer;
7. Patients with skin damage or infection at the treatment site；
8. Patients with serious systemic diseases (cardiovascular disease, liver disease, kidney disease, diabetes, etc.);
9. Patients with implanted pacemakers;
10. Patients who have participated or are participating in clinical trials of other drugs or medical devices within 3 months;
11. Female patients who are pregnant or lactating;
12. Other conditions that the investigator considers unsuitable for participation in this clinical trial
Indication
Exclusion
Surgical 
Exclusion
Clinical Trial
Exclusion
评价方法
Clinical Endpoints
 主要评价指标：
 Primary Efficacy Endpoint：
末次治疗后3个月瘢痕改善有效率
Effective scar improvement rate (3 months after the last treatment);
定义：瘢痕改善有效：痤疮瘢痕临床评分量表（ECCA）评分下降率＞25%即为有效。
Definition: Effective scar improvement: A decrease of >25% in the acne scar clinical scale (ECCA) score is considered effective..
 次要评价指标:
 Secondary Efficacy Endpoints:
1. 末次治疗后3个月ECCA评分较基线的变化值；
1. Change in ECCA score from baseline to 3 months after the last treatment;
2. 末次治疗后3个月整体瘢痕质量评分（GSS）较基线的变化；
2. Change in global scar quality score (GSS) from baseline to 3 months after the last treatment;
3. 受试者治疗后即刻疼痛评分；
3. Immediate VAS pain score after treatment;
4. 受试者满意度评价；
4. Subject satisfaction evaluation;
5. 器械性能评价；
5. Device performance evaluation;
30
样本量计算
Sample Size Estimation
预计受试者数量180例（试验组和对照组各90例），根据相关文献且与统计专家和临床专家共同讨论，假设试验组与对照
组末次治疗后3个月瘢痕改善有效率均为95%，非劣效界值取10%，检验水准取单侧0.025，把握度取80%，计算所需要样本量
为每组75例，考虑15%的脱落率以及随机化需求，样本量为每组90例，共180例。
The number of subjects is expected to be 180 (90 in the treatment group and 90 in the control group). Based 
on the literature review and discussions with statistical and clinical experts, it is assumed that both the treatment 
group and the control group have an efficiency of 95% for scar improvement at 3 months after the last treatment, 
with a non-inferiority threshold of 10%, a one-tailed significance level of 0.025, and a power of 80%, the sample size 
required is calculated as 75 cases per group. Considering the 15% drop-out rate and the need for randomization, the 
sample size is 90 cases per group, totaling 180 cases.
31
32
试验流程图
试验过程 筛选期 治疗期 随访期
时间点 筛选 首次治疗 第二次治疗 第三次治疗 末次治疗后1个月 末次治疗后3个月
窗口期 -7~0天 第0天 第30±7天 第60±7天 ±15天 ±15天
观察形式 来院 来院 来院 来院 电话/来院 来院
知情同意 X
一般资料 X
生命体征 X X X X X
既往病史 X
入选/排除标准 X
凝血检查 X
妊娠检查 X
拍摄照片 X X X X
ECCA权重评分 X X
GSS评分 X X
传染四项 X
随机分组 X
射频治疗 X X X
器械性能评价 X X X
疼痛评分 X X X
受试者满意度 X X
用药情况 X X X X X X
不良事件 X X X X X X
33
Flow Chart
Trial period Screening Period of treatment Period of follow-up
Visit 1 Screening 2 First 
treatment
3 Second 
treatment
4 Third 
treatment
5 one month after 
the last treatment
6 three months after 
the last treatment
Time Window -7~0d 0d 30±7d 60±7d ±15d ±15d
Visit Method Return to 
hospital
Return to 
hospital
Return to 
hospital
Return to 
hospital
Phone call/Return to 
hospital Return to hospital
Informed consent X
Demographics X
Vital sign X X X X X
Medical History X
Inclusion/exclusion criteria X
Coagulation test X
Pregnancy test X
Take pictures X X X X
ECCA score X X
GSS score X X
Infectious Diseases test X
Randomization X
Radiofrequency therapy X X X
Device performance evaluation X X X
Pain score X X X
Subject satisfaction X X
Medication usage X X X X X X
Adverse events X X X X X X
临床执行
Clinical trial execution
35
INTRAcel黄金微针部分用户
序号 医院名 医院名 医院名 医院名
1 北京301医院-国际医学中心 莫琳娜整形美容医院 上海丽铂医疗美容 银川靓鑫整形美容医院
2 北京小忠丽格医疗美容医院 哈尔滨超龙整形美容医院 上海喜美医疗美容 南通玫瑰整形医院
3 北京安加医疗美容诊所 烟台华美整形美容医院 上海镜面医疗整形医院 安徽蚌埠多妍医疗美容整形医院
4 北京伊芙丽格医疗美容诊所 南阳华美整形美容医院 上海海华医院 海宁康华医疗整形医院
5 北京维斯可尔医疗美容医院 广州恒大-天津原辰医疗美容医院 上海锐芃健康管理中心 海宁康华医疗整形医院
6 南方皮肤病医院 南京皮肤研究所 上海首尔丽格医疗美容医院 深圳玛楚医疗美容门诊部
7 生命汇 郑州大学第五附属医院 上海医颜医疗门诊部 深圳芙必优诊所
8 北京禾力康医疗美容医院 四川医学美容中心 上海生命树医疗集团 深圳小珂丽格医疗美容诊所
9 北京蝶恋谷美容 四川华博医学美容医院 上海康斯美医疗美容门诊部 深圳福田希诺医疗美容诊所
10 大庆俪云整形美容医院 成都瑞贝玛医疗美容机构 上海凯思米医疗美容门诊部 重庆小珂丽格医疗美容诊所
11 北京基恩医院 上海第九人民医院（学术研究） 杭州整形医院 金华永康沁薇医疗美容门诊部
12 北京恒大原辰整形美容医院 上海柔伊医疗美容 杭州博雅整形美容医院 杭州醉美桃花源医疗美容
13 北京王府井医院 上海星采医疗整形医院 浙江杭州华尔倍丽医疗美容门诊部 北京幸福心医疗美容诊所
14 北京泽尔医疗美容诊所 上海纽菲思医疗美容门诊部 浙江宁波素颜 重庆斯启诺Skinnos皮肤科医院
15 西婵整形美容医院 上海瑞芙臣医疗美容 义乌张晓红整形美容医院 武汉斯启诺Skinnos皮肤科医院
16 深圳时光海医疗美容诊所 杭州星博体医疗美容医院 南通星范医疗美容
36
Part of users of INTRAcel RadioFrequency Microneedling
Serial number Hospital Hospital Hospital Hospital
1 Beijing 301 Hospital - International Medical Center Molina Plastic Surgery Hospital Shanghai Liplatinum Medical cosmetology Yinchuan Liangxin plastic surgery hospital
2 Beijing Xiaozhong Lige Medical Cosmetology Hospital Harbin Chaolong Plastic Surgery Hospital Shanghai Ximi Medical Cosmetology Nantong Rose Plastic Surgery Hospital
3 Beijing Anga Medical beauty Clinic Yantai Huamei plastic surgery Hospital Shanghai Mirror Medical Plastic Surgery Hospita Anhui Bengbu Duoyan Medical cosmetic plastic 
hospital
4 Beijing Eveliger Medical Cosmetic Clinic Nanyang Huamei plastic surgery Hospital Shanghai Haihua Hospital Haining Kanghua Medical Plastic Hospital
5 Beijing Visco Medical Cosmetology Hospital Guangzhou Evergrande - Tianjin Yuanchen Medical 
Cosmetology Hospital Shanghai Rupeng Health Management Center Haining Kanghua Medical Plastic Hospital
6 Dermatology Hospital of Southern Medical Univerity Nanjing Institute of Dermatology Shanghai Ligue Medical Beauty Hospital Shenzhen Ma Chu medical cosmetology outpatient 
department
7 Life Infinity The Fifth Affiliated Hospital of Zhengzhou University Shanghai Yiyan Medical outpatients Department Shenzhen Fubiyou Clinic
8 Beijing Helikang Medical Cosmetic Hospital Sichuan Medical Cosmetology Center Shanghai Life Tree Medical Group henzhen small Keliger medical beauty clinic
9 Beijing butterfly love Valley beauty Sichuan Huabo Medical Cosmetology Hospital Shanghai KangsiMei Medical Clinic Shenzhen Futian Xinuo medical cosmetic clinic
10 Daqing Liyun plastic surgery hospital Chengdu Rui Beima medical beauty institutions Shanghai Kaismi Medical cosmetology Clinic Chongqing small keliger medical beauty clinic
11 Beijing Kean Hospital Shanghai Ninth People's Hospital (Academic Research) Hangzhou Plastic Surgery Hospital Jinhua Yongkang Qin Wei medical cosmetology 
outpatient department
12 Beijing Evergrande Yuanchen Plastic Surgery Hospital Shanghai Rui Yi Medical Cosmetology Hangzhou Boya Plastic Surgery Hospital Hangzhou drunken beauty peach blossom source 
medical cosmetology
13 Beijing Wangfujing Hospital Shanghai Xingcai Medical Plastic Hospital Zhejiang Hangzhou Walberry Medical cosmetology 
Clinic Beijing Happy Heart Medical cosmetic clinic
14 Beijing Zell Medical cosmetic clinic Shanghai Nuffis Medical cosmetology Clinic Ningbo, Zhejiang province Chongqing Skinnos Dermatology Hospital
15 Xichan Plastic Surgery Hospital Shanghai Riverson Medical Cosmetology Yiwu Zhang Xiaohong plastic surgery hospital Wuhan Skinnos Dermatology Hospital
16 Shenzhen ShiGuangHai medical beauty clinic Shanghai Riverson Medical Cosmetology Nantong Xingfan Medical cosmetic
37
临床试验机构
Clinical Trial Sites
序号
No.
医院名
Hospital
主任名
Director of 
Department
既往项目月入组量
Monthly enrollment in
previous projects
有无对照
With or without 
controls
1 中国人民解放军解放军第七医学中心
PLA Seventh Medical Center
杨蓉娅
Yang RongYa 5 无
No
2 北京医院
Beijing Hospital
赵红艺
Zhao HongYi 10 无
No
3
南方皮肤病医院
Dermatology Hospital of Southern 
Medical Univerity
杨斌
Yang Bin 10 有
Yes
38
项目周期
Project cycle
项目阶段
Phase of the project
项目
Project
周期/月
Period/Month
阶段1
Phase 1
与CRO签订合同
Contract with CRO
阶段2
Phase 2
方案撰写、中心筛选、方案讨论会
Protocol writing, center screening, protocol seminar 1.5
阶段3
Phase 3
通过牵头单位伦理委员会审核并获得伦理批件
Ethics approval obtained from the ethics committee of the coordinating site 1.5
阶段4
Phase 4
通过其他临床试验机构伦理委员会审核并取得伦理批件
Ethics approval obtained from the ethics committees of other sites
2
阶段5
Phase 5
参研中心协议、遗传办审批
Study sites agreement, Genetic Office approval 3
阶段6
Phase 6
中心启动会→完成入组
Center Launch meeting → Complete enrollment 8
阶段7
Phase 7
完成入组→完成治疗
Complete enrollment → Complete treatment 2
阶段8
Phase 8
完成治疗→完成随访
Complete treatment → Complete follow-up
3
阶段9
Phase 9
收集CRF（如需），解答Query，数据管理、统计分析
Collecting CRF (if needed), answering queries, data management and statistical analysis 2
阶段10
Phase 10
总结报告、中心关闭
Summary report, center close 2
总计
Total 23-25
39
项目监管
Project supervision
执行内容
Content of execution
频次
Frequency
主导方
Leading party
备注
Remarks
进度监管
Progress Monitor
1月/次
Once per month
运营总监
Department Manager
沟通和进度
Communication 
and progress
电话会议
Conference call
待定
To be determined
PM和申办方
PM and the Sponsor
月报
Monthly report
每月一次
Once per month
临床支持部
Clinical Support 
Department
监查
Monitor and control
每月
Once per month PM/CRA
质量
Quality 质控
Quality control
2次/中心
twice per center
QA经理
QA Manager
中期分析
Interim Analysis
1次
1 time
项目经理和医学经理
PM&MW 结果监测
Outcomes 
Monitor 数据审核会
Data review 
Conference
1次
1 time
项目经理和医学经理
PM&MW
客户反馈
Customer feedback
每半年一次
Once every six months
商务部
Business Department
服务
Services
临床试验重难点
Key points of clinical trials
难点：
 对照组和试验组，同一治疗部位的治疗参数保持基本一致；
The treatment parameter should be basically consistent between the control group and the experimental 
group.
重点：
 ECCA评分盲评；
Blind rating was performed using ECCA.
 物资供给及时（麻药，耗材等）；
Timely supply of materials (anesthetics, consumables, etc.)
 拍照（各中心遵循同一SOP，每中心固定一人拍照，评分标准一致，VISA拍照备用）；
Take photos:
1. All sites must follow the same SOP; 
2. Choose a specific person responsible for taking photos in each site; 
3. Develop a uniform scoring standard; 
4. Use VISA to take pictures for backup.
 招募预筛储备。
Recruit subjects in advance.
40
41
临床试验策略评估-优势
Clinical Trial Strategy Assessment - Strengths
全部在中国
All in China
部分在中国
Partly in China
服从GCP监管执行：
Subject to GCP supervision and 
execution:
1. 医学设计：符合中国的医学标准即可；
1. Medical design: meet the Chinese medical criteria;
2. 临床执行：全部的中国研究者，再学术方面较为；
2. Clinical execution: all Chinese investigators, and 
more academic;
3. 项目管理：中国备案；
3. Project management: Domestic record;
4. 结果监测：方便监测；
4. Results monitor: convenient;
5. 质量管理：方便管理；
5. Quality control: convenient;
6. 试验结果影响力：相对弱。
6. Power of trial outcome: Relatively weak.
服从ICH-GCP监管执行
Subject to ICH-GCP supervision and execution
1. 医学设计：符合参与成员国的医学标准，样本量要考虑亚组分析，需要各个亚组皆满足统计要求。临床试验样本变大；
1. Medical design: meet the medical criteria of the participating member countries; the calculation of sample 
size needs to consider the subgroup analysis, and each subgroup needs meet the statistical assumption. 
Result in larger samples size;
2. 临床执行：中韩皆备案、方案变更需要满足两国要求、需要想ICH-GCP成员国递交资料；难度增大、周期增长、预算
增加；
2. Clinical execution: record in both South Korea and China, protocol changes need to meet the requirements 
of both countries, and data should be submitted to ICH-GCP member countries. Result in greater difficulty, 
longer period and higher budget; 
3. 项目管理：跨国管理，沟通协调成本增加；
3. Project management: Cross-country management, increased communication and coordination costs;
4. 质量管理：需要满足ICH-GCP质量和流程要求，增加了质量管理成本；
4. Quality control: need to meet ICH-GCP quality and process requirements, increased 
quality control costs;
5. 试验结果影响力：相对强。
5. Power of trial outcome: Relatively strong.
4242
涵盖临床试验全流程的SOP—MD/FM/MD
SOP-MD-OP-001 医疗器械临床试验流程
SOP-MD-OP-002 项目组内部沟通
SOP-MD-OP-003 公司内部沟通
SOP-MD-OP-004 公司外部沟通
SOP-MD-OP-005 项目团队的建立
SOP-MD-OP-006 项目组成员培训
SOP-MD-OP-007 中心筛选及确认
SOP-MD-OP-008 项目日常管理
SOP-MD-OP-009 试验文档管理
SOP-MD-OP-010 临床试验物资管理
SOP-MD-OP-011 试验方案的起草、审核
SOP-MD-OP-012 ICF、CRF等资料起草、审核
SOP-MD-OP-013 研究者会议
SOP-MD-OP-014 独立伦理委员会的审批
SOP-MD-OP-015 中心协议签署
SOP-MD-OP-016 试验用医疗器械管理
SOP-MD-OP-017 研究中心启动
SOP-MD-OP-018 临床常规监查
…… ……
SOP-MD-OP-037 临床试验数据交接
SOP-MD-FM-001 项目文件夹一览表
SOP-MD-FM-002 项目文档借阅表
SOP-MD-FM-003 项目文件销毁清单表
SOP-MD-FM-004 临床试验项目资料印刷
SOP-MD-FM-005 中心联系名录
SOP-MD-FM-006 员工培训签到表
SOP-MD-FM-007 影像交接记录表（和CL）
SOP-MD-FM-008 研究者会议签到表
SOP-MD-FM-009 临床试验物品交接表
SOP-MD-FM-010 临床试验文件交接表
SOP-MD-FM-011 医疗器械运送及接受记录表
SOP-MD-FM-012 温、湿度记录表-内部（如适用）
SOP-MD-FM-013 温、湿度记录表-中心（如适用）
SOP-MD-FM-014 医疗器械分发记录表（按受试者）
SOP-MD-FM-015 医疗器械回收/退货记录表（按中心）
SOP-MD-FM-016 医疗器械入库清单
…… ……
SOP-MD-FM-034 受试者退出记录表
SOP-MD-TP-001 项目进度汇报模板
SOP-MD-TP-002 项目周报/月报
SOP-MD-TP-003 项目简报
SOP-MD-TP-004 保密协议
SOP-MD-TP-005 项目运营管理计划
SOP-MD-TP-006 项目监查计划
SOP-MD-TP-007 项目预算表
SOP-MD-TP-008 项目文件夹目录（ISF、TMF-site、
TMF-trial）
SOP-MD-TP-009 项目文件夹标签模板
SOP-MD-TP-010 文件说明记录
SOP-MD-TP-011 临床试验协议模板
SOP-MD-TP-012 会议纪要
SOP-MD-TP-013 研究者会议日程
SOP-MD-TP-014 风险与问题列表
SOP-MD-TP-015 会议邀请函
SOP-MD-TP-016 会议任务分解模板
…… ……
SOP-MD-TP-018 递交信
4343
Sop-md /FM/MD covering the whole clinical trial process
SOP-MD-OP-001 Medical device clinical trial process
SOP-MD-OP-002 Communication within the project 
team
SOP-MD-OP-003 Internal communication
SOP-MD-OP-004 External communication
SOP-MD-OP-005 Establishment of the project team
SOP-MD-OP-006 Training of project team members
SOP-MD-OP-007 Center screening and confirmation
SOP-MD-OP-008 Daily project management
SOP-MD-OP-009 Trial document management
SOP-MD-OP-010 Clinical trial materials management
SOP-MD-OP-011 Drafting and review of the trial 
protocol
SOP-MD-OP-012 Drafting and review of the ICF, CRF 
and other data
SOP-MD-OP-013 Investigator Conference
SOP-MD-OP-014 Approval from an independent ethics 
committee
SOP-MD-OP-015 Center Agreement signing
SOP-MD-OP-016 Management of experimental medical 
devices
SOP-MD-OP-017 Site Launch
SOP-MD-OP-018 Routine clinical monitoring
…… ……
SOP-MD-OP-037 Clinical trial data handover
SOP-MD-FM-001 List of project folders
SOP-MD-FM-002 Project Document checkout sheet
SOP-MD-FM-003 Project file destruction checklist
SOP-MD-FM-004 Printing of clinical trial project documents
SOP-MD-FM-005 Sites Contact List
SOP-MD-FM-006 Employee training sign-in sheet
SOP-MD-FM-007 Image handover record form (and CL)
SOP-MD-FM-008 Investigator conference sign-in sheet
SOP-MD-FM-009 Clinical trial materials handover form
SOP-MD-FM-010 Clinical trial documents handover form
SOP-MD-FM-011 Medical equipment delivery and acceptance 
record form
SOP-MD-FM-012 Temperature and Humidity record sheet -
Internal (if applicable)
SOP-MD-FM-013 Temperature and Humidity Record Form -
Sites (if applicable)
SOP-MD-FM-014 Medical Device Distribution Record Form 
SOP-MD-FM-015
(by subject)
Medical Device 
(according to sites)
recall/return record form 
SOP-MD-FM-016 Inventory list of medical devices
…… ……
SOP-MD-FM-034 Subjects’ withdraw record form
SOP-MD-TP-001 Project progress report template
SOP-MD-TP-002 Weekly/monthly project report
SOP-MD-TP-003 Project Brief
SOP-MD-TP-004 Confidentiality Agreements
SOP-MD-TP-005 Project operation management plan
SOP-MD-TP-006 Project monitoring plan
SOP-MD-TP-007 Project budget form
SOP-MD-TP-008 Project folder directory（ISF、TMF-site、
TMF-trial）
SOP-MD-TP-009 Project folder label template
SOP-MD-TP-010 Documentation description record
SOP-MD-TP-011 Clinical trial protocol template
SOP-MD-TP-012 Meeting minutes
SOP-MD-TP-013 Investigator Conference Schedule
SOP-MD-TP-014 List of risks and issues
SOP-MD-TP-015 Conference invitation letter
SOP-MD-TP-016 Meeting task breakdown template
…… ……
SOP-MD-TP-018 Submission letter
44
临床试验管理系统-CTMS管理系统
项目终止
创建项目 方案审核 创建账号
项目完成
添加项目/中心/人
员信息
项目过程管理
Admin PM
PM/CRA/CTA
阶段审核
同意
监查/质控管理
项目暂停
PM PM
PM CRA/QC
重新启动
草稿 项目准备
进行中
暂停 终止
已完成
Admin
申请立项 PM
Admin
PM
试验过程线上实时管理
质量、进度、计划实时掌控！
1. 临床研究
2. 项目总览
3. 中心与中心人员
4. 项目组人员
5. 进度计划
6. 费用管理
7. 审查备案
8. 受试者管理
9. 监查管理
10. 稽查管理
11. 风险管理
12. 沟通培训记录
13. 个人事务
45
Clinical Trial management System-CTMS 
management system
Termination of 
project
Create project Protocol 
review
Create an 
account
Project 
completion
Add 
project/site/staff
information
Project process 
management
Admin PM
PM/CRA/CTA
Stage 
review
agree
Monitoring/qualit
y control 
management
Suspensio
n of 
project
PM PM
PM CRA/QC
restart
draft Project Preparation
In progress
pause
termination
finished
Admin
Application for 
project approval PM
Admin
PM
Real-time online management of the trial 
process 
Real-time quality, progress, plan control
1. Clinical Trial
2. Project Overview 
3. Sites and staff
4. Project team members 
5. Schedule of progress 
6. Management of expenses 
7. Review and record 
8. Management of subjects 
9. Management of monitor
10. Management of audit 
11. Risk management 
12. Communication and training 
records
13. Personal affairs 
46
甲乙双方职责
甲方 乙方
1. 提供符合中国要求的注册检测报告；
2. 提供与本临床试验相关的公司资质；
3. 负责国家局备案工作；
4. 提供临床试验对照品及说明书（中文）；
5. 负责清关工作，将试验产品运输到国内；
6. 负责按照乙方要求，对各临床试验机构进行配货；
7. 试验用器械使用培训；
8. 负责购买与临床试验相关的受试者术后美容用品；
9. 负责购买临床试验责任险；
10. 按照乙方要求配合乙方拜访研究者；
11. 临床试验相关文件盖章邮寄；
12. 配合乙方为开展本临床试验所需必要工作等
1. 临床试验方案及配套文件撰写；
2. 临床试验机构筛选；
3. 立项伦理的资料准备及递交直至完成伦理批件；
4. 起草和沟通主协议文件，并支付相应款项；
5. 遗传办审批文件递交及问题回复；
6. 临床试验启动会组织和培训；
7. 临床试验质量管理；
8. 临床试验进度管理；
9. 临床试验文件管理；
10. 临床试验结果管理；
11. 临床试验总结报告撰写及盖章；
12. 临床试验结题；
47
Responsibilities of both parties
Party A Party B
1. Provide the registered test report that meets the requirements of 
China;
2. Provide company qualifications related to the clinical trial;
3. To be responsible for the filing of the NMPA;
4. Provide clinical trial devices and instructions of control group (in 
Chinese);
5. Responsible for customs clearance and transportation of 
experimental devices to China;
6. Responsible for dispensing products to each clinical sites according 
to Party B's requirements;
7. Training on the use of experimental device;
8. Responsible for the purchase of subjects' postoperative cosmetic 
products related to the clinical trial;
9. Responsible for the purchase of clinical trial liability insurance;
10. Cooperate with Party B to visit the investigators according to Party 
B's requirements;
11. Stamp and mail the documents related to the clinical trial;
12. Cooperate with Party B to carry out the necessary work for the 
clinical trial.
1. Clinical trial protocol and supporting documents 
writing;
2. Screening of clinical trial sites;
3. Preparation and submission of ethics materials 
until obtaining the ethics approval documents;
4. Draft and communicate the primary agreement 
document, and make the corresponding payment;
5. Submit approval documents and reply questions 
to the Genetic Office;
6. Clinical trial launch conference organization and 
training;
7. Clinical trial quality control;
8. Clinical trial progress management;
9. Clinical trial document management;
10. Clinical trial results management;
11. Clinical trial summary report writing and 
stamping;
12. Clinical trial closure.
感谢！
Thank you!
联系方式：
Contact Information:
盛恩（北京）医药科技有限公司
Thinova (Beijing) Medical Science andTechnology Co., Ltd.
毛世杰：15761685859
15761685859
shijie.mao@thinova.net
www.thinova.net
